Bill C-224: Should Supplements Escape Vanessa's Law?
A Conservative private member's bill would take away Health Canada's power to recall natural health products, order label changes, and fine companies. The Health Committee deleted every clause in October. The fight now moves to the floor of the House.
The short version
- What it is: Bill C-224, An Act to amend the Food and Drugs Act (natural health products). Sponsor: Blaine Calkins, Conservative MP for Ponoka–Didsbury, Alberta.
- What it would do: take vitamins, herbal remedies, homeopathics, probiotics and other natural health products (NHPs) out of the "therapeutic products" safety regime they joined in 2023.
- Where it stands: second reading passed unanimously on 10 March 2026. On 7 October the Liberal majority on the Standing Committee on Health voted to delete every clause. Report stage is next. The bill's backers say it is set for 3 December, when Calkins can move to restore the deleted text.
How we got here: Vanessa's Law
In March 2000, fifteen-year-old Vanessa Young of Oakville collapsed and died of a heart arrhythmia. She had been taking the prescription stomach drug cisapride (Prepulsid), which was later pulled from the market. Her father, Terence Young, went on to become a Conservative MP and spent years campaigning for stronger drug-safety law. The result was the Protecting Canadians from Unsafe Drugs Act (Bill C-17), known as Vanessa's Law. It received Royal Assent on 6 November 2014 under the Harper government.
Vanessa's Law gave Health Canada powers it had not had before. It can order a recall, order a label change, compel a company to hand over safety information or run new studies, and require hospitals to report serious adverse reactions. Natural health products were deliberately left out. They stayed under the lighter Natural Health Products Regulations of 2004, and the industry's trade group, the Canadian Health Food Association, publicly congratulated Young when the law passed.
What changed in 2023
In April 2021 the Commissioner of the Environment and Sustainable Development, part of the Auditor General's office, tabled an audit of Health Canada's NHP program. Its findings were blunt:
- 88% of the sampled products were advertised with misleading information, including health claims Health Canada had never authorized.
- 56% carried misleading label information.
- Health Canada did not always verify that manufacturing sites followed good manufacturing practices before products went on sale.
- More than 91,000 NHPs had been licensed since 2004 without routine inspections.
Health Canada accepted the findings. It then extended Vanessa's Law to natural health products through the 2023 budget bill, Bill C-47 (Division 27 of Part 4), which received Royal Assent on 22 June 2023. Putting the change in an omnibus budget bill, rather than a stand-alone health bill, is the grievance at the root of everything that followed.
What Bill C-224 would actually do
- Redefine "therapeutic product" in the Food and Drugs Act so that it excludes natural health products. Nicotine replacement therapies stay in, through an amendment first proposed by the Bloc Québécois.
- Repeal sections 21.321 and 21.8(2) of the Act, two of the provisions that apply the 2023 oversight powers to NHPs.
- Add a transitional clause halting prosecutions for certain NHP offences committed between the 2023 changes and the bill coming into force.
In practical terms, Health Canada would lose its Vanessa's Law tools for supplements: mandatory recalls, ordered label changes, compelled safety information, and the stronger penalty regime. Licensing under the 2004 regulations would remain. NHPs would still need a product licence (an NPN) to be sold.
Timeline
| Date | Event |
|---|---|
| 6 Nov 2014 | Vanessa's Law (C-17) receives Royal Assent, with NHPs excluded. |
| 22 Apr 2021 | Environment Commissioner's audit tabled: 88% misleading advertising, 56% misleading labels. |
| 22 Jun 2023 | Budget bill C-47 receives Royal Assent, extending Vanessa's Law to NHPs. |
| 2024 | Calkins's first attempt, Bill C-368, passes second reading with NDP and Bloc support and clears the Health Committee. Then-Health Minister Mark Holland calls reversing the changes "cuckoo bananas." |
| 2025 | C-368 dies on the Order Paper when Parliament is prorogued and the election is called. |
| 18 Sep 2025 | Calkins reintroduces the bill as C-224. |
| 17 Nov 2025 | Second-reading debate opens. |
| 10 Mar 2026 | Second reading passes unanimously. The bill is referred to the Health Committee (HESA). |
| Jun–Oct 2026 | HESA hearings. Witnesses include the Canadian Health Food Association and Shawn Buckley of the Natural Health Products Protection Association (NHPPA). |
| 7 Oct 2026 | The committee's Liberal majority votes to delete every clause. |
| 21 Oct 2026 | The committee reports the gutted bill back to the House. |
| 3 Dec 2026* | Report stage, where motions to reinsert the deleted clauses can be moved. *Date as given by the NHPPA. Check LEGISinfo. |
The case on both sides
For the bill
- Process. A change this large was slipped into a budget bill without proper debate. Calkins called it "underhanded" and "sneaky." The NDP also objected to using an omnibus bill to do it.
- Small business. Conservatives say the new fees and red tape threaten a $5.5-billion industry made up largely of small firms, many of them owned by women.
- Low risk. Supporters argue NHPs are far safer than drugs. One brief to the committee noted that NHPs made up 0.6% of adverse-reaction reports in 2020.
- Proportionality. The Bloc has questioned whether pharmaceutical-style penalties and cost recovery fit a sector of small and medium-sized businesses.
- Choice. Calkins says more than 80% of Canadians rely on these products and that the rules threaten affordable access to vitamins, protein powders and probiotics.
Against the bill
- Lost powers. Health Canada would lose the ability to order a recall, force a label change, or fine a company over a dangerous or mislabelled supplement.
- The audit. The government's own auditor found misleading advertising on 88% of sampled products. Stripping enforcement tools after that finding is hard to defend.
- "Natural" isn't "harmless." Health Canada notes that NHPs are generally lower risk but not risk-free. Adulterated products, interactions with prescription drugs, and liver injury are real.
- Pharmacists' view. The Canadian Pharmacists Association backed the 2023 change, saying NHPs should have been covered in 2014.
- Amnesty. The bill would also halt prosecutions for offences already committed. That is a gift to whoever broke the law in the meantime.
QuackeryWatch's view
The process complaint is legitimate. A safety regime affecting tens of thousands of products deserved its own bill and its own hearings, not a few clauses buried in a budget. But a bad process is an argument for a proper review, not for tearing the protections out.
The "low risk" statistic proves less than it seems. NHPs produced few adverse-reaction reports in 2020 partly because nobody was required to report them. Hospitals had to report drug reactions, not supplement reactions. Mandatory reporting is how we find out how safe these products really are. Removing it guarantees we never know.
It is also worth remembering whose law this is. Vanessa's Law came from a Conservative MP who lost his daughter to a product that was presumed safe, and it was passed by a Conservative government. Extending it to supplements doesn't ban a single vitamin. It means that when a product is contaminated or dangerous, Health Canada can pull it off the shelf.
Who is behind the campaign
The grassroots push for C-224 is led by the Natural Health Products Protection Association (NHPPA) and its president, lawyer Shawn Buckley (long based in Kamloops, BC, now in Alberta), who testified at the Health Committee. See our profile, Shawn Buckley: The Lawyer Behind the Supplement Lobby. Its current "Last Chance" campaign asks supporters to contact their MP once a day until 3 December. Buckley has written that the committee's decision "will cause death and suffering," and that because NHPs are legally classed as drugs they cannot be sold without a Health Canada licence. That licensing requirement dates from 2004. Bill C-224 would not change it.
Calkins also sat on the panel at MP Dean Allison's September 2026 COVID vaccine-injury hearings on Parliament Hill. We covered that event in The Allison Inquiry's American Guests.
What you can do
- Tell your MP what you think before report stage. The bill's supporters are writing every day. Find your MP at ourcommons.ca/members.
- Follow the bill on LEGISinfo, Parliament's official tracker.
- Check any product you buy: see our guide, What an NPN on the label does and doesn't mean.
- Report a bad reaction to a supplement through Health Canada's MedEffect Canada page.
Sources
- Parliament of Canada, LEGISinfo: C-224 (45-1), status and committee meetings.
- openparliament.ca, Bill C-224, debate record (second reading, 17 Nov 2025).
- Build Canada, C-224 bill analysis (sections repealed, transitional clause).
- Conservative Party of Canada, Calkins statement on committee defeat.
- The Albertan, "Ponoka-Didsbury MP's natural health products bill defeated".
- NHPPA, "Last Chance to Save Bill C-224", and Shawn Buckley, Vitality Magazine column.
- Commissioner of the Environment and Sustainable Development, Report 2, Natural Health Products, Health Canada (2021).
- Health Canada, Extending Vanessa's Law to natural health products.
- Health Canada, Vanessa's Law (Bill C-17), 2014.
- Senate SOCI Committee, CHFA testimony on C-47 (2023).
- Canadian Press via Powell River Peak, "Conservatives are trying to loosen regulations on natural health products" (C-368, Holland quote).
- openparliament.ca, Bill C-368 (44-1).
- HESA brief, April 2026 (0.6% adverse-reaction statistic).